Please login to the form below

Not currently logged in
Email:
Password:

Neopharm

This page shows the latest Neopharm news and features for those working in and with pharma, biotech and healthcare.

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

The Merck agreement comes four years after Fresenius hived off its biotech business to the owners of Israeli group Neopharm, saying it wanted to narrow down its focus to intravenous drugs,

Latest news

  • Fresenius sells biotech business Fresenius sells biotech business

    German healthcare group Fresenius has sold its biotech business for an undisclosed amount to the owners of Neopharm, Israel's second-largest pharma company. ... David Fuhrer, chairman and CEO of Neopharm, said: "The acquisition represents a cornerstone

  • Novartis gains licence for GW's Sativex

    Sativex is licensed to Otsuka Pharmaceutical in the US, to Almirall in Europe (excluding the UK), to Bayer HealthCare in the UK and Canada, and to Neopharm Group in Israel/Palestine.

  • Going for gold

    Additionally, NeoPharm's liposomal candidate, LEP-ETU, is expected to enter phase II clinical trials for breast cancer in 2008.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics